Home > Boards > US Listed > Biotechs >

Invitae Corp. (NVTA)

Add NVTA Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 1/20/2021 9:15:37 PM - Followers: 20 - Board type: Free - Posts Today: 0

Genetics is the future of medicine.

Our vision.

Invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people.

Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today.

What’s our plan? It takes three steps:

Make genetic testing more affordable and accessible than ever before.
Build a secure and trusted genome management infrastructure.
Design a new global community for sharing genetic information to advance science and medicine.
Today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. Together we can improve healthcare for billions of people.
Making genetic testing affordable and accessible.

Today, Invitae can deliver results for any genetic test in our catalog for $1,500 in an average of three weeks.

As a part of that catalog, the company currently offers the following panels:

Featured cancer panels

BRCA1 and BRCA2, including full gene sequencing and deletion/duplication analysis
Hereditary breast cancer, high-risk panel (7 genes)
Hereditary breast cancer, extended panel (12 genes)
Women’s hereditary cancer panel (18 genes associated with hereditary breast, ovarian and endometrial cancer)
Lynch syndrome (5 genes)
Hereditary colon cancer, high-risk panel(7 genes)
Hereditary colon cancer (14 genes)
Hereditary pancreatic cancer (17 genes)
Hereditary cancer syndromes panel (29 genes)
Featured cardiology panels

Brugada syndrome (10 genes)
Long QT syndrome (13 genes)
Hypertrophic cardiomyopathy (16 genes)
Short QT syndrome (6 genes)
Featured neurology panels

Charcot-Marie Tooth disease (28 genes)
Hereditary spastic paraplegia (17 genes)
Additionally, Invitae is committed to improving family health by leveraging the power of genetic information and innovative technologies. The “Invitae Family History Tool” is the first free family history collection app that enables genetic counselors to digitally build, modify, share, and save their patients’ pedigrees.

Learn more about the Family History Tool.
An unparalleled team.

Invitae has assembled a team of more than 130 of the world’s foremost experts in genetics, bioinformatics, engineering, technology, and commercial development, among other disciplines. The company was founded in 2012 by CEO Randy Scott (co-founder of Genomic Health [Nasdaq: GHDX] and Incyte [Nasdaq: INCY]) through an investment in Locus Development, founded by Sean George, Michele Cargill, Alex Furman and Mat Falkowski.

Since its inception, Invitae has collectively raised $207 million.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVTA News: Invitae to Present at the Oppenheimer 31st Annual Healthcare Conference 03/04/2021 07:30:00 AM
NVTA News: Pharming Group, in collaboration with Invitae Corporation, launches genetic testing program 'navigateAPDS' in US and Canada 03/02/2021 01:00:00 AM
NVTA News: Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) 02/26/2021 05:38:21 PM
NVTA News: Statement of Changes in Beneficial Ownership (4) 02/26/2021 05:31:37 PM
NVTA News: Securities Registration: Employee Benefit Plan (s-8) 02/26/2021 04:36:23 PM
#94   $400M offering today AH when they have $400M BuyLow_Sell_High 01/20/21 09:15:37 PM
#93   jerseyboy, Congrats. JJ8 01/10/21 09:06:24 PM
#92   I have finally come to understand that the jerseyboy 01/02/21 03:29:25 PM
#91   63 a share last week...WHAT HAPPENED?? moneymaker290 12/29/20 04:33:08 PM
#90   Really good information presented this past week. Read timetravelerdos 12/12/20 10:56:53 AM
#89   Invitae to Present New Data Supporting Genetic Testing timetravelerdos 12/09/20 09:27:50 AM
#88   i added a few today on the upgrade. PENNYBUSTER 11/03/20 06:02:27 PM
#87   Buddy alerted me to this, same friend alerted Porterhouse10 07/13/20 11:50:46 AM
#86   Science is well established here. lhughbees 07/13/20 09:24:13 AM
#85   NVTA 50/200sma crossed bullish on the chart Friday. Golden_Cross 06/28/20 01:56:11 PM
#84   * * $NVTA Video Chart 06-22-2020 * * ClayTrader 06/22/20 04:36:52 PM
#83   NVTA up 15% today after Motley Fool recommendation. Gpheart2016 02/06/20 01:52:15 PM
#82   News: $NVTA Invitae Announces Program with BioMarin to whytestocks 12/10/19 10:15:23 PM
#81   News: $NVTA Invitae Launches Invitae Discover Research Platform whytestocks 11/15/19 02:15:22 PM
#80   Looks like that article was on point. Thanks. half-full 11/15/19 11:45:02 AM
#79   $NVTA bears and bulls https://news.squeezereport.com/short-squeeze/i whytestocks 11/14/19 05:25:25 PM
#78   News: $NVTA Invitae to Acquire Clear Genetics whytestocks 11/11/19 07:45:23 AM
#77   News: $NVTA University of Vermont Health Network begins whytestocks 11/08/19 07:00:23 PM
#76   https://www.thestreet.com/markets/invitae-shares-rise-after-andrew-left-goes-lon Reversemergers 08/29/19 03:19:45 PM
#75   Happy here since $18. The science is good Reversemergers 08/23/19 02:51:45 PM
#74   In my opinion, today is just the beginning PEACHMAN 08/09/19 10:42:20 AM
#73   AL says NVTA TP is $100 serious38 08/07/19 10:02:15 AM
#72   I can't answer that. It could happen fast martin33 08/05/19 12:41:03 PM
#71   I wonder if there is a little time The Rainmaker 08/05/19 11:57:01 AM
#70   DAMS Consulting says shorts are getting ready to blast martin33 08/05/19 11:35:31 AM
#69   DAMS Consulting Don'tDrinkTheKoolAid 08/05/19 11:34:46 AM
#68   Pump job is Failing MISERABLY here..BIG DROP COMING. The Rainmaker 08/05/19 11:31:50 AM
#67   19.50 first support. martin33 08/05/19 10:54:45 AM
#66   Low 24's company has no profits either. Don'tDrinkTheKoolAid 08/05/19 10:49:15 AM
#65   Nice analysis went with my theory too. Don'tDrinkTheKoolAid 08/05/19 10:36:09 AM
#64   NVTA just hit 25.00. Downward reversal on Point martin33 08/05/19 09:40:24 AM
#63   Way over priced. Big correction coming. martin33 08/04/19 11:37:05 PM
#62   Agree 100 pct. Way over priced. Free fall coming. martin33 08/04/19 11:31:58 PM
#61   NVTA over priced garbage. Time to short this Don'tDrinkTheKoolAid 08/03/19 07:53:40 PM
#60   News: $NVTA Invitae to Acquire Singular Bio to whytestocks 06/17/19 04:00:51 PM
#59   Real pleased to have enjoyed the SP's astounding shub 06/12/19 02:52:27 PM
#58   NVTA & IMLFF massive ROI potential.... Fress 03/10/19 01:23:58 PM
#57   Sure am; shub 12/11/18 01:29:15 PM
#56   You still in this? Thedeadman 11/29/18 08:33:57 PM
#55   It was around 5 or 6$ when i shub 09/19/18 02:02:39 PM
#54   It got pretty darn low there and hasn't shub 05/21/18 03:14:23 PM
#53   Been wanting to buy, just won't pullback any, madprophet 05/21/18 02:42:37 PM
#52   Yeah: I'm no trader..Research, buy and squat on shub 05/10/18 04:50:09 PM
#51   I believe you are right-- great potential. Eye chmcnfunds 05/10/18 04:22:41 PM
#50   Too soon. shub 05/10/18 03:46:26 PM
#49   Out for now @ $5.67 near the EOD. chmcnfunds 04/11/18 04:05:33 PM
#48   Very nice, was hoping for +10%, but keeps chmcnfunds 04/11/18 01:32:05 PM
#47   InVitae +3.7% as Baker Bros. reports 12.6% stake chmcnfunds 04/11/18 10:05:04 AM
#46   Up after hours (but can't trade with E-trade chmcnfunds 04/10/18 04:17:26 PM
#45   Invitae research highlights utility of proactive genetic screening, chmcnfunds 04/10/18 09:28:41 AM
Consent Preferences